John W. Huemoeller II - Mar 15, 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Stock symbol
AXIM
Transactions as of
Mar 15, 2024
Transactions value $
$250,000
Form type
4
Date filed
3/19/2024, 07:14 PM
Previous filing
Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $250K +1 +0% $250,000.00* 42.5M Mar 15, 2024 Common Stock 12.5M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.